azosemide has been researched along with bumetanide in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Göttl, KH; Klinke, R; Roesch, A | 1 |
| Ross, MD | 1 |
| Diener, M; Hörger, S; Schultheiss, G | 1 |
| Hampel, P; Löscher, W; MacAulay, N; Römermann, K | 1 |
| Gramer, M; Hampel, P; Löscher, W; Römermann, K | 1 |
| Gailus, B; Gericke, B; Hampel, P; Johne, M; Kaczmarek, E; Löscher, W; Römermann, K | 1 |
| Gramer, M; Kirchhoff, L; Löscher, W; Schmidt, R; Welzel, B | 1 |
8 other study(ies) available for azosemide and bumetanide
| Article | Year |
|---|---|
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Quantitative evaluation of ototoxic side effects of furosemide, piretanide, bumetanide, azosemide and ozolinone in the cat--a new approach to the problem of ototoxicity.
Topics: Action Potentials; Animals; Bumetanide; Cats; Cochlea; Diuretics; Dose-Response Relationship, Drug; Female; Furosemide; Hearing Disorders; Kidney; Male; Sulfanilamides; Sulfonamides; Thiazoles | 1985 |
The effects of diuretics on Reissner's membrane.
Topics: Animals; Blood Urea Nitrogen; Bumetanide; Cochlea; Cochlear Duct; Diuretics; Ethacrynic Acid; Furosemide; Rats; Rats, Inbred Strains; Sulfanilamides; Sulfonamides | 1981 |
The bumetanide-resistant part of forskolin-induced anion secretion in rat colon.
Topics: Animals; Antiporters; Bicarbonates; Bumetanide; Carrier Proteins; Chloride Channels; Chloride-Bicarbonate Antiporters; Chlorides; Colforsin; Colon; Diuretics; Dose-Response Relationship, Drug; Drug Resistance; Female; Furosemide; Male; Rats; Rats, Wistar; Sodium-Potassium-Chloride Symporters; Sulfanilamides; Sulfonamides | 1998 |
Azosemide is more potent than bumetanide and various other loop diuretics to inhibit the sodium-potassium-chloride-cotransporter human variants hNKCC1A and hNKCC1B.
Topics: Animals; Biological Transport; Brain; Bumetanide; Chlorides; Diuretics; Homeostasis; Humans; Sodium Potassium Chloride Symporter Inhibitors; Solute Carrier Family 12, Member 2; Sulfanilamides | 2018 |
The search for brain-permeant NKCC1 inhibitors for the treatment of seizures: Pharmacokinetic-pharmacodynamic modelling of NKCC1 inhibition by azosemide, torasemide, and bumetanide in mouse brain.
Topics: Animals; Brain; Bumetanide; Endothelial Cells; Humans; Mice; Seizures; Sodium Potassium Chloride Symporter Inhibitors; Solute Carrier Family 12, Member 2; Sulfanilamides; Torsemide | 2021 |
Effects of the NKCC1 inhibitors bumetanide, azosemide, and torasemide alone or in combination with phenobarbital on seizure threshold in epileptic and nonepileptic mice.
Topics: Animals; Anticonvulsants; Bumetanide; Drug Therapy, Combination; Epilepsy; Female; Mice; Phenobarbital; Pilocarpine; Seizures; Sodium Potassium Chloride Symporter Inhibitors; Solute Carrier Family 12, Member 2; Sulfanilamides; Torsemide; Treatment Outcome | 2021 |
The loop diuretic torasemide but not azosemide potentiates the anti-seizure and disease-modifying effects of midazolam in a rat model of birth asphyxia.
Topics: Animals; Asphyxia; Bumetanide; Diuretics; Epilepsy; Furosemide; Rats; Sodium Potassium Chloride Symporter Inhibitors; Solute Carrier Family 12, Member 2; Torsemide | 2023 |